$HZNP Recent Headlines Thursday’s biggest gain
Post# of 89355
Posted On: 03/05/2014 11:01:13 AM
$HZNP Recent Headlines
Thursday’s biggest gaining and declining stocks 3:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 8:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 8:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 5:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 9:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 11:00 a.m. July 28, 2011 - MarketWatch.com
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 6:31 a.m. Today - benzinga.com
Biopharms That Won't Buy The Farm - Investment Ideas 3:37 p.m. Feb. 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Upgraded (HZNP) 10:11 a.m. Feb. 25, 2014 - TheStreet.com
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:36 a.m. Feb. 25, 2014 - Zacks.com
Should You Worry About the Short Interest in Horizon Pharma (HZNP)? - Tale of the Tape 10:13 a.m. Feb. 24, 2014 - Zacks.com
Horizon Pharma (HZNP) Shares March Higher, Can It Continue? - Tale of the Tape 9:14 a.m. Feb. 21, 2014 - Zacks.com
Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs 3:44 p.m. Feb. 11, 2014 - benzinga.com
Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2% - Tale of the Tape 9:25 a.m. Jan. 30, 2014 - Zacks.com
5 Pharmaceutical Stocks to Buy Now 3:15 a.m. Jan. 24, 2014 - InvestorPlace.com
Affymetrix's Revenue Guidance Tops Ests - Analyst Blog 2:50 p.m. Jan. 8, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy? - Tale of the Tape 8:40 a.m. Dec. 13, 2013 - Zacks.com
Horizon Pharma rallies again following Cramer comment 2:31 p.m. Nov. 21, 2013 - Seeking Alpha
Jim Cramer: Buy Fluor, Home Depot, and These 2 Stocks 9:56 a.m. Nov. 21, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - Halcon Is Not Bringing Home The Bacon (11/20/13) 7:34 a.m. Nov. 21, 2013 - Seeking Alpha
Horizon: Hold Or Take Profit Now? 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
Horizon Pharma's CEO Presents at Agreement to Acquire U.S. Rights to Vimovo Conference (Transcript) 3:50 p.m. Nov. 19, 2013 - Seeking Alpha
Horizon Pharma: Speculative Small Cap Moving On News 3:09 p.m. Nov. 19, 2013 - Seeking Alpha
Ford Avoids Big Sedan Recall and 2 Other Hot Stocks to Watch 12:38 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Horizon Pharma Deal Ramps Up Profitability Timeline 11:37 a.m. Nov. 19, 2013 - 247WallSt.com
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:31 a.m. Today - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:31 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:41 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:51 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:31 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:30 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 5, 2013 - Marketwire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Marketwire
Strategic Acquisitions, New Drug Applications, Licensing Agreements, and Financial Results - Research Report on Horizon Pharma, NPS Pharmaceuticals, Spherix, Evoke Pharma, and POZEN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
Thursday’s biggest gaining and declining stocks 3:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 8:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 8:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 5:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 9:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 11:00 a.m. July 28, 2011 - MarketWatch.com
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 6:31 a.m. Today - benzinga.com
Biopharms That Won't Buy The Farm - Investment Ideas 3:37 p.m. Feb. 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Upgraded (HZNP) 10:11 a.m. Feb. 25, 2014 - TheStreet.com
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:36 a.m. Feb. 25, 2014 - Zacks.com
Should You Worry About the Short Interest in Horizon Pharma (HZNP)? - Tale of the Tape 10:13 a.m. Feb. 24, 2014 - Zacks.com
Horizon Pharma (HZNP) Shares March Higher, Can It Continue? - Tale of the Tape 9:14 a.m. Feb. 21, 2014 - Zacks.com
Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs 3:44 p.m. Feb. 11, 2014 - benzinga.com
Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2% - Tale of the Tape 9:25 a.m. Jan. 30, 2014 - Zacks.com
5 Pharmaceutical Stocks to Buy Now 3:15 a.m. Jan. 24, 2014 - InvestorPlace.com
Affymetrix's Revenue Guidance Tops Ests - Analyst Blog 2:50 p.m. Jan. 8, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
Earnings Estimates Moving Higher for Horizon Pharma (HZNP): Time to Buy? - Tale of the Tape 8:40 a.m. Dec. 13, 2013 - Zacks.com
Horizon Pharma rallies again following Cramer comment 2:31 p.m. Nov. 21, 2013 - Seeking Alpha
Jim Cramer: Buy Fluor, Home Depot, and These 2 Stocks 9:56 a.m. Nov. 21, 2013 - Wall St. Cheat Sheet
Cramer's Lightning Round - Halcon Is Not Bringing Home The Bacon (11/20/13) 7:34 a.m. Nov. 21, 2013 - Seeking Alpha
Horizon: Hold Or Take Profit Now? 9:02 a.m. Nov. 20, 2013 - Seeking Alpha
Horizon Pharma's CEO Presents at Agreement to Acquire U.S. Rights to Vimovo Conference (Transcript) 3:50 p.m. Nov. 19, 2013 - Seeking Alpha
Horizon Pharma: Speculative Small Cap Moving On News 3:09 p.m. Nov. 19, 2013 - Seeking Alpha
Ford Avoids Big Sedan Recall and 2 Other Hot Stocks to Watch 12:38 p.m. Nov. 19, 2013 - Wall St. Cheat Sheet
Horizon Pharma Deal Ramps Up Profitability Timeline 11:37 a.m. Nov. 19, 2013 - 247WallSt.com
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:31 a.m. Today - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:31 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:41 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:51 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:31 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:30 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 5, 2013 - Marketwire
Healthcare Sector Announces Voluntary Recalls, Scheduled Presentations and Offering Programs - Research Report on Baxter, Incyte, Horizon Pharma, POZEN, and IntelliPharmaCeutics 8:00 a.m. Dec. 2, 2013 - PR Newswire
Horizon Pharma to Present at the Piper Jaffray 25th Annual Healthcare Conference 7:30 a.m. Nov. 26, 2013 - Marketwire
Strategic Acquisitions, New Drug Applications, Licensing Agreements, and Financial Results - Research Report on Horizon Pharma, NPS Pharmaceuticals, Spherix, Evoke Pharma, and POZEN 8:00 a.m. Nov. 22, 2013 - PR Newswire
Disaster Relief Contributions, New Medical Trials, Clinical Results and Employee Incentives - Research Report on UnitedHealth Group, ACADIA, USANA, Portola and Horizon Pharma 8:00 a.m. Nov. 21, 2013 - PR Newswire
(0)
(0)